Standout Papers

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after fa... 2012 2026 2016 2021 760
  1. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial (2012)
    Vincent A. Miller, Vera Hirsh et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 15 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

The neuroscience of cancer
2023 StandoutNature
Petabase-scale sequence alignment catalyses viral discovery
2022 StandoutNature
2 intermediate papers

Works of Yan Sun being referenced

ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway
2015
Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer
2008

Author Peers

Author Last Decade Papers Cites
Yan Sun 1338 1327 1239 123 3.5k
Qin Li 1125 1269 1092 152 3.8k
Takeshi Ueda 1916 1195 1779 154 4.2k
Thomas C. Hall 630 1171 1219 152 4.0k
Masahiko Nishiyama 821 1319 1594 187 3.3k
Mark Garzotto 1886 780 1039 116 3.7k
Dov Kadmon 2094 860 1480 125 4.4k
Gábor Méhes 561 775 1090 165 2.7k
Jung Han Kim 910 944 1071 148 3.3k
Angelo Sidoni 945 1209 1030 186 3.6k
You‐Yang Zhao 1446 946 2544 80 5.5k

All Works

Loading papers...

Rankless by CCL
2026